Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?

Published by
The Street

By Maxx Chatsko Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning. Investors are increasingly hearing how artificial intelligence may make drug development more efficient. It’s far from science fiction. Pfizer (PFE) – Get Pfizer Inc. Report leaned on advanced computational modeling to develop an antiviral drug that could be taken orally, had robust activity against SARS-CoV-2, and had an acceptable safety profile. The drug, now available under the brand name Paxlovid, was discovered in only four months – less than half the time typically required. …

Read More

See also  Ken Griffey Jr Has 1 Potential NBA Game Circled: Fans React

Leave a Reply